Skip to content

Efficiency of the Super Inductive System in Spasticity Treatment

Efficiency of the Super Inductive System in Spasticity Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04190238
Enrollment
60
Registered
2019-12-09
Start date
2019-12-04
Completion date
2022-12-31
Last updated
2022-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spasticity, Muscle

Brief summary

The aim of the study is to see whether a physical therapy program can relieve pain, decrease spasticity and increase muscle contraction force by using the super inductive system (high frequency electromagnetic field). It is a longitudinal, prospective study, of 60 patients with spasticity after stroke. No new treatment method is tested, as the Super inductive system is approved for physical therapy by the Ministry of Health.

Detailed description

The 60 patients will be submitted to 2 treatment groups: 30 patients will receive 10 sessions of the superinductive system on the antagonist muscles, and 30 patients will receive 10 sessions the superinductive system on the agonist and antagonist muscles. All patients will also receive the standard kinetotherapy program for spasticity. The patients will be evaluated at the beginning of the treatment, at 10 days and at 30 days by using the functional MAS index and Barthel index.

Interventions

OTHERSuper inductive system (high frequency electromagnetic field)

Super inductive system (high frequency electromagnetic field)

OTHERPhysical therapy

specific for spasticity

Sponsors

Iuliu Hatieganu University of Medicine and Pharmacy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Intervention model description

case-control study

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* spasticity after stroke

Exclusion criteria

* spasticity of other causes

Design outcomes

Primary

MeasureTime frameDescription
change in MAS functional indexday 0, day 10, day 30upper extremity functional index
change in Barthel indexday 0, day 10, day 30measurement of activities of daily living

Countries

Romania

Contacts

Primary ContactAlina D Ciubean, MD
alina.deniza.ciubean@gmail.com0040744635364

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026